TNXP — Tonix Pharmaceuticals Holding Share News
0.000.00%
- $88.67m
- -$87.56m
- $13.11m
Brief: Tonix Pharmaceuticals And Kenya Medical Research Institute To Design, Plan And Seek Regulatory Approval For Phase I Clinical Study Of TNX-801 For Mpox In Kenya
Brief: Tonix Pharmaceuticals Announces Submission Of The TNX-102 Sl New Drug Application (NDA) For Fibromyalgia To The U.S. Food And Drug Administration (FDA)
Brief: Tonix Pharmaceuticals Entered Into An AI And ML Research Collaboration With X-Chem
Brief: Tonix Pharmaceuticals Holding Corp Files For Mixed Shelf Offering Of Upto $300 Million- SEC Filing
Brief: Tonix Pharmaceuticals Announces Issuance Of U.S. Patent For FDA-Approved Tosymra® To Treat Migraines
Brief: Tonix Pharmaceuticals Announces That Its Single Dose Mpox Vaccine Candidate Tnx-801 Aligns With Who's Newly Issued Preferred Target Product Profile For Mpox Vaccines In Global Health Emergency
U.S. STOCKS ON THE MOVE-Tesla, Icahn Enterprises, Boeing
U.S. STOCKS ON THE MOVE-Boeing, Tesla, Icahn Enterprises
U.S. STOCKS ON THE MOVE-XPeng, SolarEdge, SentinelOne
Tonix climbs on partnership to develop mpox vaccine
GeoVax tumbles on deep-discounted direct stock offering
Brief: Tonix Pharmaceuticals Announces First Patient Enrolled In Phase 2 Catalyst Study Of Tnx-1300 For Treatment Of Cocaine Intoxication
Mpox-linked stocks extend rally into second week
Mpox vaccine developer GeoVax extends gains, rival Tonix Pharma jumps
Tonix Pharmaceuticals Holding Corp reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-B Riley, Energy stocks, Pharma stocks
U.S. STOCKS ON THE MOVE-regular hours
U.S. STOCKS ON THE MOVE-Crypto stocks, H&R Block, Coherent Corp
Tonix Pharma surges on plans to advance mpox vaccine development